3 completed, 2 terminated, 1 withdrawn. 6 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Terminated 2, Withdrawn 1 |
| Phase 1 | 2 | Completed 2 |
Follow Methoxydimethyltryptamines: new trials by email Literature Review of Methoxydimethyltryptamines trials Research Report on Methoxydimethyltryptamines
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trifecta Research Study Hormone Replacement Therapy (HRT), Magnetic Resonance Therapy (MeRT), ibogaine with magnesium treatment - PTSD - Post Traumatic Stress Disorder, Cognitive Dysfunction | Phase 2 | Withdrawn | Johns Hopkins University | 2025-09-01 | 2025-08-22 | |
| Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety BMND08, Brain electrical activity monitor, Pharmacokinetic Study of Sublingually Administered Psychoactive Substance - Healthy Volunteers | Phase 1 / Phase 2 | Completed | Biomind Labs Inc. | 40 | 2024-10-21 | 2025-03-05 |
| A Trial of GH001 in Patients With Treatment-resistant Depression GH001, Placebo - Treatment-resistant Depression | Phase 2 | Completed | GH Research Ireland Limited | 81 | 2023-05-24 | 2025-05-31 |
| Phase 2 Clinical Trial of GH001 in Bipolar II Disorder GH001 - Bipolar II Disorder | Phase 2 | Terminated | GH Research Ireland Limited | 6 | 2023-04-06 | 2025-02-18 |
| Phase 2 Clinical Trial of GH001 in Postpartum Depression GH001 - Postpartum Depression, Postnatal Depression | Phase 2 | Terminated | GH Research Ireland Limited | 10 | 2023-03-02 | 2025-02-18 |
| Clinical Study of GH001 in Depression 5 Methoxy N,N Dimethyltryptamine - Treatment Resistant Depression, Major Depressive Disorder | Phase 1 / Phase 2 | Completed | GH Research Ireland Limited | 16 | 2019-11-12 | 2023-08-15 |
Depression (5) · Depressive Disorder, Major (2) · Depressive Disorder, Treatment-Resistant (2) · Anxiety Disorders (1) · Bipolar Disorder (1) · Brain Injuries (1) · Brain Injuries, Traumatic (1) · Cognitive Dysfunction (1) · Combat Disorders (1) · Depression, Postpartum (1) · Mood Disorders (1) · Stress Disorders, Post-Traumatic (1)
GH Research Ireland Limited (4) · Biomind Labs Inc. (1) · Johns Hopkins University (1)
Netherlands (4) · Germany (2) · United Kingdom (2) · Argentina (1) · Czechia (1) · Ireland (1) · Poland (1) · Spain (1) · United States (1)
Martin A. Bruno, PhD (1) · Sandeep Nayak, MD (1)
PMID 37409159, PMID 40659913, PMID 41879760, PMID 42247279
2018 (1)